Stock 2342 TRANS GENIC INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Trans Genic Inc.

Equities

2342

JP3635720000

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-21 EDT 		5-day change 1st Jan Change
229 JPY -0.43% Intraday chart for Trans Genic Inc. -4.98% -11.92%
01-24 Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on November 22, 2023. CI
01-23 Trans Genic Inc.'s Equity Buyback announced on November 22, 2023, has closed with 300,000 shares, representing 1.78% for ¥78.62 million. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Final dividend
FA
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on November 22, 2023.
CI
Trans Genic Inc.'s Equity Buyback announced on November 22, 2023, has closed with 300,000 shares, representing 1.78% for ¥78.62 million.
CI
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on November 22, 2023.
CI
Trans Genic Inc. announces an Equity Buyback for 300,000 shares, representing 1.78% for ¥100 million.
CI
Trans Genic Inc. authorizes a Buyback Plan.
CI
Trans Genic Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Ex-dividend day for final dividend
FA
Anniversary bonus dividend
FA
Trans Genic Inc. acquired MASC Co., Ltd.
CI
Ex-dividend day for final dividend
FA
Eurofins Clinical Testing Lux Holding Sarl entered into a share purchase agreement to acquire GeneticLab Co., Ltd. from Trans Genic Inc. for ¥3.2 billion.
CI
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on August 25, 2021.
CI
Trans Genic Inc.'s Equity Buyback announced on August 25, 2021, has closed with 550,000 shares, representing 3.19% for ¥298.6 million.
CI
Trans Genic Inc. completed the acquisition of Lunapas LLC.
CI
Tranche Update on Trans Genic Inc.'s Equity Buyback Plan announced on August 25, 2021.
CI
Trans Genic Inc. entered into share transfer agreement to acquire Lunapas LLC.
CI
Trans Genic Inc. announces an Equity Buyback for 550,000 shares, representing 3.17% for ¥300 million.
CI
Trans Genic Inc. authorizes a Buyback Plan.
CI
Kikuyo Sakaguchi cancelled the acquisition of remaining 30% stake in Immunokick Inc. from Trans Genic Inc..
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2342 Stock
  4. News Trans Genic Inc.
  5. Highlights
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW